A biotech startup reports that an AI agent selected a gene therapy and carried out an injection into a live mouse’s brain. The claim, as described by outlets, centers on the agent’s ability to decide on the treatment and steer the needle while human oversight remains present.
Medium and Science Latest both frame the work as a demonstration of how autonomous or semi-autonomous systems could be used inside research labs. Medium notes that Exin Therapeutics says it had a veterinarian and an emergency stop available during the procedure, and also indicates that no peer-reviewed paper is available yet. Science Latest similarly emphasizes that the agent injected drugs into a live mouse’s brain and highlights the implication for the future of laboratory research, presenting the effort as an early glimpse rather than established consensus.